Cargando…
Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study
Eplets are defined as distinct amino acid configurations on the surface of HLA molecules. The aim of this study was to estimate the immunogenicity of HLA‐DQ eplets in a cohort of 221 pregnancies with HLA‐DQ mismatches. We defined the immunogenicity of an eplet by the frequency of antibody responses...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756751/ https://www.ncbi.nlm.nih.gov/pubmed/33068062 http://dx.doi.org/10.1111/tan.14110 |
_version_ | 1783626609890164736 |
---|---|
author | Schawalder, Lara Hönger, Gideon Kleiser, Marc van Heck, Michelle R. van de Pasch, Loes A. L. Vendelbosch, Sanne Rozemuller, Erik H. Schaub, Stefan |
author_facet | Schawalder, Lara Hönger, Gideon Kleiser, Marc van Heck, Michelle R. van de Pasch, Loes A. L. Vendelbosch, Sanne Rozemuller, Erik H. Schaub, Stefan |
author_sort | Schawalder, Lara |
collection | PubMed |
description | Eplets are defined as distinct amino acid configurations on the surface of HLA molecules. The aim of this study was to estimate the immunogenicity of HLA‐DQ eplets in a cohort of 221 pregnancies with HLA‐DQ mismatches. We defined the immunogenicity of an eplet by the frequency of antibody responses against it. Around 90% of all listed DQB1 or DQA1 eplets were at least five times mismatched and thus included for the calculation of their immunogenicity. The DQB1 eplets with the five highest immunogenicity scores were 55PP, 52PR, 52PQ, 85VG and 45EV; 25% of all DQB1 eplets were not reacting. The DQA1 eplets with the five highest immunogenicity scores were 25YS, 47QL, 55RR, 187T and 18S; 17% of all DQA1 eplets were not reacting. The immunogenicity score had a slightly higher area under the curve to predict development of child‐specific antibodies than various molecular mismatch scores (eg, eplet mismatch load, amino acid mismatch load). Overlapping eplets were identified as a barrier to unambiguously assign the immunogenicity score based on HLA antibody reaction patterns. In this conceptual study, we explored the immunogenicity of HLA‐DQ eplets and created a map of potentially immunogenic regions on HLA‐DQ molecules, which requires validation in clinical transplant cohorts. |
format | Online Article Text |
id | pubmed-7756751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-77567512020-12-28 Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study Schawalder, Lara Hönger, Gideon Kleiser, Marc van Heck, Michelle R. van de Pasch, Loes A. L. Vendelbosch, Sanne Rozemuller, Erik H. Schaub, Stefan HLA Original Articles Eplets are defined as distinct amino acid configurations on the surface of HLA molecules. The aim of this study was to estimate the immunogenicity of HLA‐DQ eplets in a cohort of 221 pregnancies with HLA‐DQ mismatches. We defined the immunogenicity of an eplet by the frequency of antibody responses against it. Around 90% of all listed DQB1 or DQA1 eplets were at least five times mismatched and thus included for the calculation of their immunogenicity. The DQB1 eplets with the five highest immunogenicity scores were 55PP, 52PR, 52PQ, 85VG and 45EV; 25% of all DQB1 eplets were not reacting. The DQA1 eplets with the five highest immunogenicity scores were 25YS, 47QL, 55RR, 187T and 18S; 17% of all DQA1 eplets were not reacting. The immunogenicity score had a slightly higher area under the curve to predict development of child‐specific antibodies than various molecular mismatch scores (eg, eplet mismatch load, amino acid mismatch load). Overlapping eplets were identified as a barrier to unambiguously assign the immunogenicity score based on HLA antibody reaction patterns. In this conceptual study, we explored the immunogenicity of HLA‐DQ eplets and created a map of potentially immunogenic regions on HLA‐DQ molecules, which requires validation in clinical transplant cohorts. Blackwell Publishing Ltd 2020-10-28 2021-01 /pmc/articles/PMC7756751/ /pubmed/33068062 http://dx.doi.org/10.1111/tan.14110 Text en © 2020 The Authors. HLA: Immune Response Genetics published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Schawalder, Lara Hönger, Gideon Kleiser, Marc van Heck, Michelle R. van de Pasch, Loes A. L. Vendelbosch, Sanne Rozemuller, Erik H. Schaub, Stefan Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study |
title | Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study |
title_full | Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study |
title_fullStr | Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study |
title_full_unstemmed | Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study |
title_short | Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study |
title_sort | development of an immunogenicity score for hla‐dq eplets: a conceptual study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756751/ https://www.ncbi.nlm.nih.gov/pubmed/33068062 http://dx.doi.org/10.1111/tan.14110 |
work_keys_str_mv | AT schawalderlara developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy AT hongergideon developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy AT kleisermarc developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy AT vanheckmicheller developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy AT vandepaschloesal developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy AT vendelboschsanne developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy AT rozemullererikh developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy AT schaubstefan developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy |